Effectiveness and Safety of Drug-Eluting Stents in Ontario
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The placement of drug-eluting stents decreases the frequency of repeat revascularization procedures in patients undergoing percutaneous coronary intervention (PCI) in randomized clinical trials. However, there is uncertainty about the effectiveness of drug-eluting stents, and increasing concern about their safety, in routine clinical practice. METHODS: From the Cardiac Care Network of Ontario's population-based clinical registry of all patients undergoing PCI in Ontario, Canada, we identified a well-balanced cohort of 3751 pairs of patients, matched on the basis of propensity score, who received either bare-metal stents alone or drug-eluting stents alone during an index PCI procedure between December 1, 2003, and March 31, 2005. The primary outcomes of the study were the rates of target-vessel revascularization, myocardial infarction, and death. RESULTS: The 2-year rate of target-vessel revascularization was significantly lower among patients who received drug-eluting stents than among those who received bare-metal stents (7.4% vs. 10.7%, P<0.001). Drug-eluting stents were associated with significant reductions in the rate of target-vessel revascularization among patients with two or three risk factors for restenosis (i.e., presence of diabetes, small vessels [<3 mm in diameter], and long lesions [> or =20 mm]) but not among lower-risk patients. The 3-year mortality rate was significantly higher in the bare-metal-stent group than in the drug-eluting-stent group (7.8% vs. 5.5%, P<0.001), whereas the 2-year rate of myocardial infarction was similar in the two groups (5.2% and 5.7%, respectively; P=0.95). CONCLUSIONS: Drug-eluting stents are effective in reducing the need for target-vessel revascularization in patients at highest risk for restenosis, without a significantly increased rate of death or myocardial infarction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Approximately 15% of patients with T2DM will require target vessel revascularization within 2 years after bare metal stenting,290”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [290]
Citations
Cites
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
Survival Analysis, Techniques for Censored and Truncated Data
Rao, M. B. (1998) · Technometrics · doi:10.1080/00401706.1998.10485206 · Cited by 3,617
Iakovou, I. (2005) · JAMA · doi:10.1001/jama.293.17.2126 · Cited by 3,132
WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,218
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents
Stone, G. W., Moses, J. W., Ellis, S. G., Schofer, J., Dawkins, K. D., Morice, M.-C., Colombo, A., Schampaert, E., Grube, E., Kirtane, A. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067193 · Cited by 1,631
Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
Pfisterer, M., Brunner-La Rocca, H. P., Buser, P. T., Rickenbacher, P., Hunziker, P., Mueller, C., Jeger, R., Bader, F., Osswald, S., & Kaiser, C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.026 · Cited by 1,303
Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden
Lagerqvist, B., James, S. K., Stenestrand, U., Lindbäck, J., Nilsson, T., & Wallentin, L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067722 · Cited by 1,197
Grines, C. L., Bonow, R. O., Casey, D. E., Gardner, T. J., Lockhart, P. B., Moliterno, D. J., O’Gara, P., & Whitlow, P. (2007) · Circulation · doi:10.1161/circulationaha.106.180944 · Cited by 1,140
Austin, P. C., Grootendorst, P., & Anderson, G. M. (2007) · Statistics in Medicine · doi:10.1002/sim.2580 · Cited by 1,137
Self-citation
Research works printed but not linked: 1
- Wilkins R, 1993, Health Rep, 5, 157
Cited by
Items 101–200 of 383
Mæng, M., Jensen, L. O., Kaltoft, A., Hansen, H. H. T., Bøttcher, M., Lassen, J. F., Thayssen, P., Krusell, L. R., Rasmussen, K., Pedersen, L. H., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.03.034 · Cited by 31
Clinical utility of platinum chromium bare-metal stents in coronary heart disease
Dubois, C., & Jorge, C. M. (2015) · Medical Devices Evidence and Research · doi:10.2147/mder.s69415 · Cited by 30
“13–15 Moreover, the benefit of DES seems to be mostly limited to the prevention of restenosis and reintervention, while patients treated with BMS or DES have similar rates of death and acute myocardial infarction (MI).”
Effect of Length and Diameter of Drug-Eluting Stents Versus Bare-Metal Stents on Late Outcomes
Applegate, R. J., Sacrinty, M. T., Kutcher, M. A., dos Santos, R. M., Gandhi, S. K., & Little, W. C. (2009) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.108.805630 · Cited by 30
The Number Needed to Treat: 25 Years of Trials and Tribulations in Clinical Research
Suissa, S. (2015) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10218 · Cited by 28
Benefits of and safety concerns associated with drug-eluting coronary stents
Garg, S., & Serruys, P. W. J. C. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.138 · Cited by 28
Revascularization strategies for patients with stable coronary artery disease
Iqbal, J., & Serruys, P. W. J. C. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12243 · Cited by 30
Pfisterer, M. E., Bertel, O., Bonetti, P. O., Rocca, H. B., Eberli, F. R., Erné, P., Galatius, S., Hornig, B., Kiowski, W., Pachinger, O. M., et al. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.11.011 · Cited by 28
Ferenc, M., Gick, M., Kienzle, R.-P., Bestehorn, H.-P., Werner, K.-D., Comberg, T., Zhao, M., Buettner, H. J., & Neumann, F. (2010) · American Heart Journal · doi:10.1016/j.ahj.2009.11.032 · Cited by 27
“Treatment of coronary bifurcation lesions is considered one of the off-label uses of DESs.”
ResultInfluentialDoes anemia impact hospital readmissions after coronary artery bypass surgery?
Shehata, N., Forster, A. J., Li, L., Rothwell, D. M., Mazer, C. D., Naglie, G., Fowler, R., Tu, J. V., Rubens, F. D., Hawken, S., et al. (2012) · Transfusion · doi:10.1111/trf.12007 · Cited by 27
Self-citationActualización en cardiología intervencionista
Pinar, E., Albarrán, A., Baz, J. A., & Mauri, J. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)70045-4 · Cited by 28
Garg, P., Wijeysundera, H. C., Yun, L., Cantor, W. J., & Ko, D. T. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.000882 · Cited by 27
“The Cardiac Care Network of Ontario maintains a prospective clinical registry of all individuals who undergo PCI in Ontario, Canada.17 All hospitals performing PCI are required to collect information on patients’ clinical characteristics, as well as procedural information on the number of stents, characteristics of ea…”
MethodInfluentialSelf-citationLandes, U., Kornowski, R., Assali, A. R., Assa, H. V., Greenberg, G., Lev, E. I., & Bental, T. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.01.009 · Cited by 26
Bental, T., Assali, A. R., Assa, H. V., Lev, E. I., Brosh, D., Fuchs, S., Battler, A., & Kornowski, R. (2010) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22507 · Cited by 25
“This outcome was sustained over time and could certainly be a major factor contributing to the survival benefit of DESs, as restenosis can be a deleterious event [16], and since a significant 30-day mortality rate has been described after repeat procedures for BMS recipients [10].”
BackgroundDisparity in drug-eluting stent utilization by insurance type
Kao, J. A., Vicuna, R. I., House, J. A., Rumsfeld, J. S., Ting, H. H., & Spertus, J. A. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.07.012 · Cited by 23
“Patients who received at least one DES, even if BMS were also deployed (n = 1,571 patients, 1.4”
ResultInfluentialBrener, S. J., Prasad, A. J., Khan, Z. H., & Sacchi, T. J. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.10.046 · Cited by 24
Ko, D. T., Wijeysundera, H. C., Udell, J. A., Vaccarino, V., Austin, P. C., Guo, H., Velianou, J. L., Lau, K., & Tu, J. V. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.04.032 · Cited by 31
Self-citationGoeree, R. A., Bowen, J. M., Blackhouse, G., Lazzam, C., Cohen, E. A., Chiu, M., Hopkins, R., Tarride, J., & Tu, J. V. (2009) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462309090254 · Cited by 24
Self-citationRoifman, I., Wijeysundera, H. C., Austin, P. C., Rezai, M. R., Wright, G. A., & Tu, J. V. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005462 · Cited by 27
Self-citationAjani, A. E., Reid, C. M., Duffy, S. J., Andrianopoulos, N., Lefkovits, J., Black, A., New, G., Lew, R., Shaw, J. A., Yan, B. P., et al. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb02113.x · Cited by 24
Sohrabi, B., Ghaffari, S., Habibzadeh, A., & Chaichi, P. (2011) · Europe PMC (PubMed Central) · doi:10.5681/jcvtr.2011.009 · Cited by 25
Roifman, I., Rezai, M. R., Wijeysundera, H. C., Chow, B. J. W., Wright, G. A., & Tu, J. V. (2015) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2015.07.006 · Cited by 28
Self-citationDrug-eluting coronary artery stents.
DEHMER, G. J., & Smith, K. (2009) · PubMed · Cited by 23
Petersen, J. L., Barron, J. J., Hammill, B. G., Cziraky, M. J., Anstrom, K. J., Wahl, P. M., Eisenstein, E. L., Krucoff, M. W., Califf, R. M., Schulman, K. A., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2009.11.031 · Cited by 23
Alfonso, F. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.029 · Cited by 23
Health Technology Assessment and Primary Data Collection for Reducing Uncertainty in Decision Making
Goeree, R. A., Levin, L., Chandra, K., Bowen, J. M., Blackhouse, G., Tarride, J., Burke, N., Bischof, M., Xie, F., & O’Reilly, D. J. (2009) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2009.01.012 · Cited by 22
Self-citationKang, D. O., Yu, C. W., Kim, H. D., Cho, J. Y., Joo, H. J., Choi, R. K., Park, J.-S., Lee, H., Kim, J. S., Park, J. H., et al. (2015) · Coronary Artery Disease · doi:10.1097/mca.0000000000000242 · Cited by 21
Yeh, R. W., Chandra, M., McCulloch, C. E., & Go, A. S. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-78 · Cited by 21
“Prior observational studies comparing outcomes for DES and BMS have not included the chronic outpatient use of cardioprotective medications, an important potential confounder [6,19,36].”
BackgroundResultCurrent Status of Percutaneous Coronary Intervention With Drug-Eluting Stents in Asia
Park, S., & Kim, Y. (2008) · Circulation · doi:10.1161/circulationaha.107.743450 · Cited by 21
Medical Therapy v. PCI in Stable Coronary Artery Disease
Wijeysundera, H. C., TOMLINSON, G. A., Ko, D. T., Džavík, V., & Krahn, M. D. (2013) · Medical Decision Making · doi:10.1177/0272989x13497262 · Cited by 21
“A propensity score–matched cohort was created by matching each patient in the DES cohort with one in the BMS cohort (a 1:1 match).(24,25) A nearest-neighbor–matching algorithm was used to match patients on the basis of the logit of their propensity score, with matching occurring if the difference in the logits of the…”
BackgroundMethodInfluentialSelf-citationDaneman, N., Guttmann, A., Wang, X., Ma, X., Gibson, D., & Stukel, T. A. (2015) · BMJ Quality & Safety · doi:10.1136/bmjqs-2014-003863 · Cited by 26
Zamani, P. L., & Kinlay, S. (2010) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22750 · Cited by 21
Ohki, T., Yokoi, H., Kichikawa, K., Kimura, T., Snyder, S. A., Ragheb, A. O., O’Leary, E. E., Jaff, M. R., Ansel, G. M., & Dake, M. D. (2014) · Journal of Endovascular Therapy · doi:10.1583/14-4753.1 · Cited by 20
Baschet, L., Bourguignon, S., Marque, S., Durand‐Zaleski, I., Teíger, E., Wilquin, F., & Lévesque, K. (2016) · Open Heart · doi:10.1136/openhrt-2016-000445 · Cited by 20
Whicher, D. M., Chalkidou, K., Dhalla, I. A., Levin, L., & Tunis, S. (2009) · Milbank Quarterly · doi:10.1111/j.1468-0009.2009.00572.x · Cited by 20
“During the study, hospitals were able to provide DES free of charge to patients enrolled in the study (Bowen et al. 2007; Tu et al. 2007).”
BackgroundGualano, S. K., Gurm, H. S., Share, D. A., Smith, D. E., Aronow, H. D., Lalonde, T. A., Bates, E., Changezi, H., McNamara, R. F., & Moscucci, M. M. (2010) · Clinical Cardiology · doi:10.1002/clc.20717 · Cited by 20
Park, G., Lee, S., Park, S., Kim, Y., Yun, S., Cho, Y., Ahn, J., Lee, J., Kim, W., Park, D., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.07.012 · Cited by 20
“However, DM still remains a major determinant of worse prognostic outcome even after DES use.(3,4) Therefore, an investigation to identify the relative efficacies of particular DES is clinically important to the physician’s choice of devices in the management of these high-risk patients.”
Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus
Grodzinsky, A., Kosiborod, M., Tang, F., Jones, P. G., McGuire, D. K., Spertus, J. A., Beltrame, J. F., Jang, J.-S., Goyal, A., Butala, N. M., et al. (2017) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.117.003553 · Cited by 20
Lee, M. S., Canan, T., Perlowski, A., Bhatia, R., Jurewitz, D. L., & Tobis, J. M. (2009) · PubMed · Cited by 20
Chhatriwalla, A. K., Decker, C., Gialde, E., Catley, D., Goggin, K., Jaschke, K., Jones, P. G., deBronkart, D., Sun, T., & Spertus, J. A. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.005139 · Cited by 20
Clinical Features of Myocardial Infarction in Young Japanese Patients
Jinnouchi, H., Sakakura, K., Wada, H., Kubo, N., Sugawara, Y., Funayama, H., Ako, J., & Momomura, S. (2013) · International Heart Journal · doi:10.1536/ihj.54.123 · Cited by 19
Biswas, S., Lefkovits, J., Liew, D., Gale, C. P., Reid, C. M., & Stub, D. A. (2018) · EuroIntervention · doi:10.4244/eij-d-18-00434 · Cited by 19
Taniwaki, M., Stefanini, G. G., Räber, L., Brugaletta, S., Cequier, A. R., Heg, D., Íñiguez, A., Kelbæk, H., Serra, A., Ostoijc, M., et al. (2015) · EuroIntervention · doi:10.4244/eijy14m07_12 · Cited by 19
Have we been misled by the ESC DES firestorm?
Cook, S., & Meier, B. (2008) · EuroIntervention · doi:10.4244/eijv3i5a95 · Cited by 19
Windecker, S., & Jüni, P. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1189 · Cited by 18
“0001) at 2 years' follow-up in a case-matched study from Ontario”
Valgimigli, M., Patialiakas, A., Thury, A. Á., Colangelo, S., Campo, G. C., Tebaldi, M., Ungi, I., Tondi, S., Roffi, M., Menozzi, A., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.07.033 · Cited by 18
Health Technology Assessment From a Canadian Device Industry Perspective
Ferrusi, I. L., Ames, D., Lim, M. E., & Goeree, R. A. (2009) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2009.01.013 · Cited by 18
Self-citationDaneman, N., Simor, A. E., & Redelmeier, D. A. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/597523 · Cited by 18
Coronary stent technology: a narrative review
Chen, D. H., & Jepson, N. S. (2016) · The Medical Journal of Australia · doi:10.5694/mja16.00444 · Cited by 18
Russell, J. A., Wellman, H., & Walley, K. R. (2018) · Journal of Intensive Care · doi:10.1186/s40560-018-0344-2 · Cited by 18
Daemen, J., van Twisk, P.-H., Kukreja, N., van Domburg, R., Boersma, E. H., de Jaegere, P. P. T., & Serruys, P. W. J. C. (2009) · EuroIntervention · doi:10.4244/eijv4i4a80 · Cited by 17
Wang, Y.-C., Shih, S.-M., Chen, Y., Hsiung, C. A., & Kuo, S. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037484 · Cited by 18
Ko, D. T., Guo, H., Wijeysundera, H. C., Zia, M. I., Džavík, V., Chu, M. W. A., Fremes, S. E., Cohen, E. A., & Tu, J. V. (2011) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2011.06.009 · Cited by 19
“The Cardiac Care Network (CCN) of Ontario maintains an ongoing prospective clinical registry of all patients undergoing cardiac catheterization, PCI, and coronary artery bypass graft (CABG) surgery (17,18).”
BackgroundSelf-citationDrug-Eluting Stents Versus Bare-Metal Stents for Off-Label Indications
Austin, D., Oldroyd, K. G., McConnachie, A., Slack, R., Eteiba, H., Flapan, A. D., Jennings, K., Northcote, R. J., Pell, A. C. H., Starkey, I. R., et al. (2008) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.108.769042 · Cited by 17
Comparison of Drug-Eluting and Bare-Metal Stents for Stable Coronary Artery Disease
Horst, B. M., Rihal, C. S., Holmes, D. R., Bresnahan, J. F., Prasad, A., Gau, G. T., Lennon, R. J., & Lerman, A. (2009) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2008.11.010 · Cited by 17
Xie, F., Bowen, J. M., Sutherland, S., Burke, N., Blackhouse, G., Tarride, J., O’Reilly, D. J., & Goeree, R. A. (2011) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.60 · Cited by 19
Self-citationTentzeris, I., Járai, R., Farhan, S., Wojta, J., Schillinger, M., Geppert, A., Nürnberg, M., Unger, G., & Huber, K. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0228-5 · Cited by 16
“Network of Ontario’s clinical registry [34] and data from the registry of Massachusetts [46] demonstrated a lower”
Method3-Year Comparison of Drug-Eluting Versus Bare-Metal Stents
Applegate, R. J., Sacrinty, M. T., Kutcher, M. A., dos Santos, R. M., Gandhi, S. K., & Little, W. C. (2009) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2008.12.010 · Cited by 16
Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?
Chhatriwalla, A. K., & Bhatt, D. L. (2008) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.108.811380 · Cited by 16
Brindis, R., & Spertus, J. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.004 · Cited by 16
Studies of Drug-Eluting Stents
Mauri, L., & Normand, S. T. (2008) · Circulation · doi:10.1161/circulationaha.108.770164 · Cited by 16
Tanajura, L. F., Feres, F., Siqueira, D. A., Abizaid, A., Fraulob, S. M., Fucci, A., Maranhão, A. M., Bartolozzi, C. G., Borges, S. M., Marcelino, D. P., et al. (2010) · Revista Brasileira de Cardiologia Invasiva · doi:10.1590/s2179-83972010000200008 · Cited by 15
Fauchier, L., Pellegrin, C., Bernard, A., Clémenty, N., Angoulvant, D., Lip, G. Y. H., & Babuty, D. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.02.042 · Cited by 15
Proximal coronary artery intervention: Stent thrombosis, restenosis and death
Calais, F., Lagerqvist, B., Leppert, J., James, S. K., & Fröbert, O. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.10.060 · Cited by 15
Lee, C. H., Kang, D., Han, M., Hur, S., Rha, S., Her, S., Seung, K., Kim, K., Lee, P.-H., Ahn, J., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.01.108 · Cited by 15
Nauta, S. T., Mieghem, N. M. V., Magro, M., Deckers, J. W., Şimşek, C., van Geuns, R., van der Giessen, W. J., de Jaegere, P. P. T., Regar, E. S., van Domburg, R. T., et al. (2011) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.23145 · Cited by 15
“To date, other large-scale registries have not yet reported long-term outcome (>3 years) in this specific patient subset [18,30,31].”
BackgroundAppleby, C. E., Mackie, K., Džavík, V., & Ivanov, J. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)70411-6 · Cited by 15
Meredith, I. T., Rothman, M. T., Ērglis, A., Parikh, K. H., Lotan, C., & for the E‐Five Investigators (2010) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22803 · Cited by 15
Safety and effectiveness of drug-eluting stents among diabetic patients: A propensity analysis
Ko, D. T., Chiu, M., Austin, P. C., Bowen, J. M., Cohen, E. A., & Tu, J. V. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.01.029 · Cited by 15
“Stent selections are based on clinicians' clinical judgment and discretion.(13) The Ontario Drug Benefit program is a government-funded drug”
BackgroundMethodResultInfluentialSelf-citationThe APPROACH study group, García‐García, H. M., Garg, S., Brugaletta, S., Morocutti, G., Ratner, R. E., Kolatkar, N. S., Kravitz, B. G., Miller, D. M., Huang, C., et al. (2011) · International journal of cardiac imaging · doi:10.1007/s10554-011-9836-z · Cited by 15
“5% was observed in the Ontario registry in those patients having target vessel revascularisation within a month of their initial PCI procedure [20].”
MethodDrug-eluting stents: A study of international practice
Austin, D., Oldroyd, K. G., Holmes, D. R., Rihal, C. S., Galbraith, P. D., Ghali, W. A., Legrand, V. M. G., Taeymans, Y., McConnachie, A., & Pell, J. P. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.07.033 · Cited by 15
“Subsequent published meta-analyses and large observational studies have since shown safety and efficacy of DES without major safety concerns.(31-36) This evidence is particularly strong for “on-label” patients studied in the pivotal randomized controlled trials, although further studies have included other important s…”
MethodThe Evolution of Thienopyridine Therapy
Choi, S., Prasad, A., & Tsimikas, S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.017 · Cited by 15
Chen, D., Mao, C., Tsai, M., Chen, S., Lin, Y., Hsieh, C., Hung, M., Wang, C., Wen, M., Cherng, W., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.014 · Cited by 14
“Given the current controversy over the benefits of DESs compared with BMSs among CS patients, a nationwide cohort study was conducted to evaluate the efficacy and safety of DESs vs. BMSs with respect to CV outcomes including mortality, myocardial infarction, stroke, coronary revascularization, and major bleeding in pa…”
ResultInfluentialInstrumental Variable Analysis to Compare Effectiveness of Stents in the Extremely Elderly
Yeh, R. W., Vasaiwala, S. C., Forman, D. E., Silbaugh, T. S., Zelevinsky, K., Lovett, A. F., Normand, S. T., & Mauri, L. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000476 · Cited by 14
Levin, L. (2015) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462315000422 · Cited by 14
“Examples, published elsewhere included drug-eluting stents (8), where restenosis rates for low risk patients were found to be similar irrespective of whether bare metal or drug eluting stents were used; positron emission tomography scanning (9) in which cancer-related indications were examined based on demonstrated cl…”
BackgroundYin, D., Li, J., Yang, Y., Wang, Y., Zhao, Y., You, S.-J., Qiao, S., Xu, B., & Dou, K. (2017) · PubMed Central · doi:10.11909/j.issn.1671-5411.2017.01.009 · Cited by 14
Marmur, J. D., Poludasu, S., Lazar, J., & Çavuşoğlu, E. (2008) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.21773 · Cited by 14
“[11] showed that in the Cardiac Care Network of Ontario’s population-based clinical registry of all patients undergoing PCI in Ontario, there was a statistically significant survival benefit with DES compared to BMS.”
ResultHarjai, K. J., Orshaw, P., Shenoy, C., Acharji, S., Sporn, D., Aboufares, A. F., & Stapleton, D. D. (2008) · Journal of Interventional Cardiology · doi:10.1111/j.1540-8183.2008.00380.x · Cited by 14
Iqbal, M. B., Nadra, I. J., Ding, L., Fung, A., Aymong, E. A., Chan, A. W., Hodge, S., Robinson, S. D., Siega, A. D., & On Behalf of the British Columbia Cardiac Registry Investigators (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26479 · Cited by 13
Influence of arterial hypotension on fractional flow reserve measurements
Verdier-Watts, F., Rioufol, G., Mewton, N., Sanchez, I., Green, L., Bonnefoy‐Cudraz, E., & Finet, G. (2015) · EuroIntervention · doi:10.4244/eijv11i4a82 · Cited by 13
Komura, N., Tsujita, K., Yamanaga, K., Sakamoto, K., Kaikita, K., Hokimoto, S., Iwashita, S., Miyazaki, T., Akasaka, T., Arima, Y., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003202 · Cited by 14
“Bifurcations with kissing balloon technique, n (%) 11 (16) 26 (14) 0.”
Patient-Centered Tablet Application for Improving Medication Adherence after a Drug-Eluting Stent
Shah, V., Dileep, A., Dickens, C., Groo, V. L., Welland, B., Field, J., Baumann, M., Flores, J. D. J. V., Shroff, A. R., Zhao, Z., et al. (2016) · Frontiers in Public Health · doi:10.3389/fpubh.2016.00272 · Cited by 12
“Failure to adhere to the medication regimen for DES is associated with an increase of 20–40% in mortality rate (3, 4, 6, 7).”
BackgroundChoi, K. H., Song, Y. B., Lee, J. M., Park, T. K., Yang, J. H., Hahn, J., Choi, J., Choi, S., Kim, H.-S., Chun, W. J., et al. (2021) · JACC Asia · doi:10.1016/j.jacasi.2021.04.006 · Cited by 13
“Nevertheless, it has been reported that there is still concern about the safety of DES; a slightly increased rate of late stent thrombosis and possibly increased rates of myocardial infarction (MI) and cardiac death after PCI (3,4).”
BackgroundHarjai, K. J., Orshaw, P., Boura, J., & Sporn, D. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.02.017 · Cited by 13
On behalf of the J-DESsERT investigators, Nakamura, M., Muramatsu, T., Yokoi, H., Okada, H., Ochiai, M., Suwa, S., Hozawa, H., Kawai, K., Awata, M., et al. (2014) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-014-0279-z · Cited by 13
Real-life management of dual antiplatelet therapy interruption: the REGINA survey
Collet, J., Aout, M., Alantar, A., Coriat, P., Napoléon, B., Thomas, D., Trosini-Desert, V., Tucas, G., Vicaut, É., & Montalescot, G. (2009) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2009.08.009 · Cited by 13
Ishii, S., Okamoto, Y., Katsumata, H., Egawa, S., Yamanaka, D., Fukushima, M., & Minami, S. (2013) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248412472258 · Cited by 14
“In the last decade, to solve this complication, several types of DES have been used successfully to decrease the rate of restenosis.(6) In DES, agents such as sirolimus, paclitaxel, and zotarolimus suppressed proliferation of VSMCs; however, in-stent thrombosis increased as a complication.”
BackgroundImpact of Drug-Eluting Versus Bare-Metal Stents on Mortality in Patients With Anemia
Shishehbor, M. H., Filby, S. J., Chhatriwalla, A. K., Christofferson, R. D., Jain, A., Kapadia, S. R., Lincoff, A. M., Bhatt, D. L., & Ellis, S. G. (2009) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2008.11.014 · Cited by 13
Barone‐Rochette, G., Machecourt, J., Vanzetto, G., Foote, A., Quésada, J.-L., Castelli, C., Danchin, N., & Combescure, C. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.054 · Cited by 12
Bae, E. H., Lim, S. Y., Choi, Y. H., Suh, S. H., Cho, K. H., Choi, J. S., Kim, C. S., Park, J. W., Kwon, S., Jeong, M. H., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0586 · Cited by 12
Bainey, K. R., Kaul, P., Armstrong, P. W., Savu, A., Westerhout, C. M., Norris, C. M., Brass, N. S., Traboulsi, D., O’Neill, B. J., Nagendran, J., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.04.109 · Cited by 12
Biondi‐Zoccai, G., Moretti, C., Lotrionte, M., & Sheiban, I. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.5.597 · Cited by 12
“Another landmark registry is the Cardiac Care Network of Ontario study, which reported on 3751 pairs of patients matched on propensity score for being treated with DES or bare-metal stents [20] .”
BackgroundResultWhy we need a national registry in interventional cardiology
Scott, I. A. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb01989.x · Cited by 12
Kurz, D. J., Bernheim, A. M., Tüller, D., Zbinden, R., Jeger, R. V., Kaiser, C. A., Galatius, S., Hansen, K. W., Alber, H. F., Pfisterer, M. E., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.07.009 · Cited by 11
Ko, D. T., Wijeysundera, H. C., Yun, L., Austin, P. C., Cantor, W. J., & Tu, J. V. (2011) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.960740 · Cited by 12
Self-citationShafiq, A., GOSCH, K. L., Amin, A. P., Ting, H. H., Spertus, J. A., & Salisbury, A. C. (2017) · Clinical Cardiology · doi:10.1002/clc.22693 · Cited by 11
Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Stenosis
Park, S., & Kim, Y. (2009) · Cardiology Clinics · doi:10.1016/j.ccl.2009.09.001 · Cited by 11
The CID Chrono™ cobalt–chromium alloy carbofilm-coated coronary stent system
Visconti, G., Focaccio, A., Tavano, D., Airoldi, F., & Briguori, C. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.01.009 · Cited by 11
Bäumler, M., Stargardt, T., Schreyögg, J., & Busse, R. (2012) · Applied Health Economics and Health Policy · doi:10.2165/11597340-000000000-00000 · Cited by 12
“Other analyses that use a PSM often apply auxiliary regressions to select variables for the PS regression.([15,16]) If a variable has a significant impact (e.”
BackgroundMethodResultInfluentialEndovascular drug-delivery and drug-elution systems
Nezami, F. R., Athanasiou, L. S., & Edelman, E. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817195-0.00028-7 · Cited by 12
Schneeweiß, S. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00607.x · Cited by 12
Metadata
- Authors
- Tu, J. V., Bowen, J., Chiu, M., Ko, D. T., Austin, P. C., He, Y., Hopkins, R., Tarride, J.-E., Blackhouse, G., Lazzam, C., Cohen, E. A., & Goeree, R.
- Affiliations
- Sunnybrook Health Science Centre (CA)
- St. Joseph’s Healthcare Hamilton (CA)
- Institute for Clinical Evaluative Sciences (CA)
- Trillium Health Centre (CA)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-10-04
- Volume
- 357
- Issue
- 14
- Pages
- 1393-1402
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2082511254
- Cited by
- 383
- References
- 35
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 11 · 2019: 7 · 2018: 5 · 2017: 13 · 2016: 15 · 2015: 28 · 2014: 15 · 2013: 15 · 2012: 34
- FWCI
- 67.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- drug-eluting stents, bare-metal stents, percutaneous coronary intervention, target vessel revascularization, restenosis, myocardial infarction, mortality, diabetes mellitus, long coronary lesions, propensity score matching, clinical registries, Ontario
- MeSH terms
- Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Ontario, Prosthesis Design, Registries, Risk Factors, Stents, Angioplasty, Balloon, Coronary, Drug Delivery Systems, Myocardial Ischemia, Disease-Free Survival, Coronary Restenosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.